ByteDance Advances AI Chip Development With Samsung Manufacturing Talks 
Salesforce Workforce Reduction Affects Fewer Than 1,000 Roles Amid Ongoing Restructuring 
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision 
Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week 
Amazon Explores AI Content Marketplace With Media Publishers 
Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year 
Samsung Electronics Shares Jump on HBM4 Mass Production Report 
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion 
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit 
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade 
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes 
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves 
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins 
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible 
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Cloudflare Forecasts Strong Revenue Growth as AI Fuels Cloud Services Demand 
WARSAW, Ind., April 09, 2018 -- OrthoPediatrics Corp. (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, today announced it will continue its Diamond sponsorship for the 37th Annual European Paediatric Orthopaedic Society (EPOS) meeting, which will take place April 11 – 14 in Oslo, Norway. OrthoPediatrics has been a leading sponsor of the Society since the Company’s inception.
At the meeting, OrthoPediatrics will also sponsor a lunch symposium titled “Management of Open Fractures in Children”, featuring a panel of key opinion leaders from around the world. The panelists will discuss the most frequent types of fractures, guidelines for antibiotic use, evidence-based surgical treatment and the management of soft tissue injuries in open fractures in children. The panel will be moderated by Dr. Pierre Journeau, with additional discussion and case presentations by Drs. Annelie Weinberg, Manoj Ramachandran, and Manon Bachy.
OrthoPediatrics’ President & CEO Mark Throdahl, commented, “We are pleased to continue our leading support of EPOS, one of the world’s largest pediatric orthopedic scientific organizations. This society has remained steadfastly dedicated to elevating the quality of care for children with orthopedic conditions. OrthoPediatrics has shared this mission since our inception, and so we are proud to continue supporting the clinical education of pediatric surgeons as we work together to improve the lives of children with orthopedic conditions around the world.”
About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on providing a comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets 24 surgical systems that serve three of the largest categories within the pediatric orthopedic market. This offering spans trauma & deformity, scoliosis and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and 37 countries outside the United States.
Investor Contacts
The Ruth Group
Tram Bui / Emma Poalillo
(646) 536-7035 / 7024
[email protected] / [email protected]
